Barta J - Search Results

1

Interventricular Differences of Signaling Pathways-Mediated Regulation of Cardiomyocyte Function in Response to High Oxidative Stress in the Post-Ischemic Failing Rat Heart.

Kovács Á, Herwig M, Budde H, Delalat S, Kolijn D, Bódi B, Hassoun R, Tangos M, Zhazykbayeva S, Balogh Á, Czuriga D, Van Linthout S, Tschöpe C, Dhalla NS, Mügge A, Tóth A, Papp Z, Barta J, Hamdani N. Kovács Á, et al. Among authors: barta j. Antioxidants (Basel). 2021 Jun 16;10(6):964. doi: 10.3390/antiox10060964. Antioxidants (Basel). 2021. PMID: 34208541 Free PMC article.

2

Calpain-1-dependent degradation of troponin I mutants found in familial hypertrophic cardiomyopathy.

Barta J, Tóth A, Jaquet K, Redlich A, Edes I, Papp Z. Barta J, et al. Mol Cell Biochem. 2003 Sep;251(1-2):83-8. Mol Cell Biochem. 2003. PMID: 14575308

3

Calpain-1-sensitive myofibrillar proteins of the human myocardium.

Barta J, Tóth A, Edes I, Vaszily M, Papp JG, Varró A, Papp Z. Barta J, et al. Mol Cell Biochem. 2005 Oct;278(1-2):1-8. doi: 10.1007/s11010-005-1370-7. Mol Cell Biochem. 2005. PMID: 16180082

4

Molecular defects in cardiac myofibrillar proteins due to thyroid hormone imbalance and diabetes.

Machackova J, Barta J, Dhalla NS. Machackova J, et al. Among authors: barta j. Can J Physiol Pharmacol. 2005 Dec;83(12):1071-91. doi: 10.1139/y05-121. Can J Physiol Pharmacol. 2005. PMID: 16462907 Review.

5

Subcellular remodeling as a viable target for the treatment of congestive heart failure.

Dhalla NS, Dent MR, Tappia PS, Sethi R, Barta J, Goyal RK. Dhalla NS, et al. Among authors: barta j. J Cardiovasc Pharmacol Ther. 2006 Mar;11(1):31-45. doi: 10.1177/107424840601100103. J Cardiovasc Pharmacol Ther. 2006. PMID: 16703218 Review.

6

Myofibrillar remodeling in cardiac hypertrophy, heart failure and cardiomyopathies.

Machackova J, Barta J, Dhalla NS. Machackova J, et al. Among authors: barta j. Can J Cardiol. 2006 Sep;22(11):953-68. doi: 10.1016/s0828-282x(06)70315-4. Can J Cardiol. 2006. PMID: 16971981 Free PMC article. Review.

7

Antiplatelet therapy attenuates subcellular remodelling in congestive heart failure.

Sanganalmath SK, Babick AP, Barta J, Kumamoto H, Takeda N, Dhalla NS. Sanganalmath SK, et al. Among authors: barta j. J Cell Mol Med. 2008 Sep-Oct;12(5A):1728-38. doi: 10.1111/j.1582-4934.2007.00197.x. Epub 2007 Dec 14. J Cell Mol Med. 2008. PMID: 18088389 Free PMC article.

8

Antiplatelet therapy mitigates cardiac remodeling and dysfunction in congestive heart failure due to myocardial infarction.

Sanganalmath SK, Barta J, Takeda N, Kumamoto H, Dhalla NS. Sanganalmath SK, et al. Among authors: barta j. Can J Physiol Pharmacol. 2008 Apr;86(4):180-9. doi: 10.1139/Y08-005. Can J Physiol Pharmacol. 2008. PMID: 18418427

9

Antiplatelet agents sarpogrelate and cilostazol affect experimentally-induced ventricular arrhythmias and mortality.

Barta J, Sanganalmath SK, Kumamoto H, Takeda N, Edes I, Dhalla NS. Barta J, et al. Cardiovasc Toxicol. 2008 Fall;8(3):127-35. doi: 10.1007/s12012-008-9019-x. Epub 2008 Aug 27. Cardiovasc Toxicol. 2008. PMID: 18751928

10

Amelioration of cardiac remodeling in congestive heart failure by beta-adrenoceptor blockade is associated with depression in sympathetic activity.

Machackova J, Sanganalmath SK, Barta J, Dhalla KS, Dhalla NS. Machackova J, et al. Among authors: barta j. Cardiovasc Toxicol. 2010 Mar;10(1):9-16. doi: 10.1007/s12012-009-9058-y. Cardiovasc Toxicol. 2010. PMID: 19949891

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

326 results

Search Page

Filters